Market Research Logo

TransGenic Inc (2342) - Financial and Strategic SWOT Analysis Review

TransGenic Inc (2342) - Financial and Strategic SWOT Analysis Review

- provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

  • Business description – A detailed description of the company’s operations and business divisions.
  • Corporate strategy – Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history – Progression of key events associated with the company.
  • Major products and services – A list of major products, services and brands of the company.
  • Key competitors – A list of key competitors to the company.
  • Key employees – A list of the key executives of the company.
  • Executive biographies – A brief summary of the executives’ employment history.
  • Key operational heads – A list of personnel heading key departments/functions.
  • Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
  • Key manufacturing facilities – A list of key manufacturing facilities of the company.
  • Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Highlights

TransGenic Inc (TransGenic) is a biotechnology company which develops and distributes genetically engineered animals and antibodies and licensing of these activities. The company’s product portfolio and services include knockout mouse and phenotype database, genetically engineered mice, custom production of knock out mouse, custom production of antibodies and proteins, drug discovery and support services, contract services for non-clinical study, mouse related products and antibody related products. TransGenic provides Gene analysis and nonclinical study using disease-animal model. The company’s technologies include, exchangeable Gene-trap method to destroy genes of a mouse and GANP Mouse to produce high-affinity antibodies. It has Kobe research centre located in japan. TransGenic is headquartered in Chuo-ku, Fukuoka City, Japan.

TransGenic Inc Key Recent Developments

Feb 06,2018: New Drug Research Center to Launch Non-Clinical Test Service Using Mouse Model of Atopic Dermatitis
Dec 06,2017: TRANS GENIC to Launch Anti-Indoxyl Sulfate Monoclonal Antibody
Nov 15,2017: TRANS GENIC to Launch New Business (New Subsidiary Company)
Aug 01,2017: TRANS GENIC Group to Launch Non-Clinical Test Service Using Mice Models of Central Nervous System Diseases

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company


Section 1 - About the Company
TransGenic Inc - Key Facts
TransGenic Inc - Key Employees
TransGenic Inc - Key Employee Biographies
TransGenic Inc - Major Products and Services
TransGenic Inc - History
TransGenic Inc - Company Statement
TransGenic Inc - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
Company Overview
TransGenic Inc - Business Description
Business Segment: Advanced medica
Overview
Performance
Business Segment: CRO
Overview
Performance
Business Segment: Genomics
Overview
Performance
Business Segment: Pathological diagnosis
Overview
Performance
Business Segment: TGBS
Overview
Performance
TransGenic Inc - Corporate Strategy
TransGenic Inc - SWOT Analysis
SWOT Analysis - Overview
TransGenic Inc - Strengths
TransGenic Inc - Weaknesses
TransGenic Inc - Opportunities
TransGenic Inc - Threats
TransGenic Inc - Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
TransGenic Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018
TransGenic Inc, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018
TransGenic Inc, Recent Deals Summary
Section 5 – Company’s Recent Developments
Feb 06, 2018: New Drug Research Center to Launch Non-Clinical Test Service Using Mouse Model of Atopic Dermatitis
Dec 06, 2017: TRANS GENIC to Launch Anti-Indoxyl Sulfate Monoclonal Antibody
Nov 15, 2017: TRANS GENIC to Launch New Business (New Subsidiary Company)
Aug 01, 2017: TRANS GENIC Group to Launch Non-Clinical Test Service Using Mice Models of Central Nervous System Diseases
Section 6 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer
List of Tables
TransGenic Inc, Key Facts
TransGenic Inc, Key Employees
TransGenic Inc, Key Employee Biographies
TransGenic Inc, Major Products and Services
TransGenic Inc, History
TransGenic Inc, Other Locations
TransGenic Inc, Subsidiaries
TransGenic Inc, Key Competitors
TransGenic Inc, Ratios based on current share price
TransGenic Inc, Annual Ratios
TransGenic Inc, Annual Ratios (Cont...1)
TransGenic Inc, Annual Ratios (Cont...2)
TransGenic Inc, Interim Ratios
TransGenic Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018
TransGenic Inc, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018
TransGenic Inc, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios
List of Figures
TransGenic Inc, Performance Chart (2014 - 2018)
TransGenic Inc, Ratio Charts
TransGenic Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018
TransGenic Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report